MACI HOBBY: Open Payments
NPI 1083018667 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 33 payments from 10 companies in 2025. Trend: 2023 $375 · 2024 $797 · 2025 $917
Food & beverage: $914Education: $2
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 8 | $339 |
| Travere Therapeutics, Inc. | 9 | $233 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Amgen Inc. | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| OPKO Pharmaceuticals, LLC | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: IBSRELA, Filspari, XPHOZAH 30 MG, Fabhalta, KRYSTEXXA, FARXIGA, KEVEYIS, Kerendia.
Industry payments across GA — which companies pay providers there.
